CN Patent

CN112243376A — 福沙匹坦的组合物和制备方法

Assigned to Sbx Pharmaceutical Co · Expires 2021-01-19 · 5y expired

What this patent protects

本申请及其实施例教导了福沙匹坦或其药学上可接受的盐的稳定组合物，其中这类组合物不含聚山梨醇酯80并且含有水解抑制和溶解度增强的双功能赋形剂。进一步描述了制备这类组合物的方法。在预期的组合物的其他优点之中，福沙匹坦水解降解保持低并且组合物维持物理和化学稳定持续延长的时间段。

USPTO Abstract

本申请及其实施例教导了福沙匹坦或其药学上可接受的盐的稳定组合物，其中这类组合物不含聚山梨醇酯80并且含有水解抑制和溶解度增强的双功能赋形剂。进一步描述了制备这类组合物的方法。在预期的组合物的其他优点之中，福沙匹坦水解降解保持低并且组合物维持物理和化学稳定持续延长的时间段。

Drugs covered by this patent

fosaprepitant-dimeglumine (FOSAPREPITANT DIMEGLUMINE)

Patent Metadata

Patent number: CN112243376A
Jurisdiction: CN
Classification: —
Expires: 2021-01-19
Drug substance claim: No
Drug product claim: No
Assignee: Sbx Pharmaceutical Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.